625 related articles for article (PubMed ID: 34117116)
1. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies.
Goldman JD; Robinson PC; Uldrick TS; Ljungman P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34117116
[TBL] [Abstract][Full Text] [Related]
2. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
3. Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.
Hartzell S; Bin S; Benedetti C; Haverly M; Gallon L; Zaza G; Riella LV; Menon MC; Florman S; Rahman AH; Leech JM; Heeger PS; Cravedi P
Am J Transplant; 2020 Nov; 20(11):3149-3161. PubMed ID: 32786152
[TBL] [Abstract][Full Text] [Related]
4. Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
Al-Ramahi JS; Shahzad M; Li K; DeJarnette S; Chaudhary SG; Lutfi F; Ahmed N; Balusu R; Bansal R; Abdelhakim H; Shune L; Singh AK; Abhyankar SH; McGuirk JP; Mushtaq MU
Leuk Lymphoma; 2023 Dec; 64(12):1981-1991. PubMed ID: 37574842
[TBL] [Abstract][Full Text] [Related]
5. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
7. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response?
Ghaffari Rahbar M; Nafar M; Khoshdel A; Dalili N; Abrishami A; Firouzan A; Poorrezagholi F; Samadian F; Ziaie S; Fatemizadeh S; Samavat S
Transpl Infect Dis; 2020 Oct; 22(5):e13406. PubMed ID: 32654357
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 in Immunocompromised Hosts: What We Know So Far.
Fung M; Babik JM
Clin Infect Dis; 2021 Jan; 72(2):340-350. PubMed ID: 33501974
[TBL] [Abstract][Full Text] [Related]
9. High-titer post-vaccine COVID-19 convalescent plasma for immunocompromised patients during the first omicron surge.
Tayyar R; Wong LK; Dahlen A; Shu E; Pandey S; Liu AY
Transpl Infect Dis; 2023 Apr; 25(2):e14055. PubMed ID: 36929619
[TBL] [Abstract][Full Text] [Related]
10. Is COVID-19 infection more severe in kidney transplant recipients?
Caillard S; Chavarot N; Francois H; Matignon M; Greze C; Kamar N; Gatault P; Thaunat O; Legris T; Frimat L; Westeel PF; Goutaudier V; Jdidou M; Snanoudj R; Colosio C; Sicard A; Bertrand D; Mousson C; Bamoulid J; Masset C; Thierry A; Couzi L; Chemouny JM; Duveau A; Moal V; Blancho G; Grimbert P; Durrbach A; Moulin B; Anglicheau D; Ruch Y; Kaeuffer C; Benotmane I; Solis M; LeMeur Y; Hazzan M; Danion F;
Am J Transplant; 2021 Mar; 21(3):1295-1303. PubMed ID: 33259686
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
Subramanian V
J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
[TBL] [Abstract][Full Text] [Related]
12. Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review.
Gopcsa L; Réti M; Andrikovics H; Bobek I; Bekő G; Bogyó J; Ceglédi A; Dobos K; Giba-Kiss L; Jankovics I; Kis O; Lakatos B; Mathiász D; Meggyesi N; Miskolczi G; Németh N; Paksi M; Riczu A; Sinkó J; Szabó B; Szilvási A; Szlávik J; Tasnády S; Reményi P; Vályi-Nagy I
Geroscience; 2024 Feb; 46(1):1083-1106. PubMed ID: 37414968
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.
Zhu L; Gong N; Liu B; Lu X; Chen D; Chen S; Shu H; Ma K; Xu X; Guo Z; Lu E; Chen D; Ge Q; Cai J; Jiang J; Wei L; Zhang W; Chen G; Chen Z
Eur Urol; 2020 Jun; 77(6):748-754. PubMed ID: 32317180
[TBL] [Abstract][Full Text] [Related]
14. Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.
La Rosa C; Chiuppesi F; Park Y; Zhou Q; Yang D; Gendzekhadze K; Ly M; Li J; Kaltcheva T; Ortega Francisco S; Gutierrez MA; Ali H; Otoukesh S; Amanam I; Salhotra A; Pullarkat VA; Aldoss I; Rosenzweig M; Aribi AM; Stein AS; Marcucci G; Dadwal SS; Nakamura R; Forman SJ; Al Malki MM; Diamond DJ
Front Immunol; 2023; 14():1114131. PubMed ID: 36936918
[TBL] [Abstract][Full Text] [Related]
15. Management of immunosuppressants in the era of coronavirus disease-2019.
Manansala M; Baughman R; Novak R; Judson M; Sweiss N
Curr Opin Pulm Med; 2021 May; 27(3):176-183. PubMed ID: 33779588
[TBL] [Abstract][Full Text] [Related]
16. Experience of SARS-CoV-2 infection in two kidney transplant recipients living with HIV-1 infection.
Chowdary P; Shetty S; Booth J; Khurram MA; Yaqoob M; Mohamed IH
Transpl Infect Dis; 2021 Apr; 23(2):e13500. PubMed ID: 33174284
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of COVID-19 Patients with Pre-existing, Compromised Immune Systems: A Review of Case Reports.
Corse T; Dayan L; Kersten S; Battaglia F; Terlecky SR; Han Z
Int J Med Sci; 2020; 17(18):2974-2986. PubMed ID: 33173418
[TBL] [Abstract][Full Text] [Related]
18. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus Disease 2019 in Immunocompromised Organ Transplant Recipients: A Case Report and Review of the Literature.
Taha M; Sharma A; Taha M; Samavati L
Transplant Proc; 2020 Nov; 52(9):2698-2702. PubMed ID: 32800516
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus.
Jakharia N; Subramanian AK; Shapiro AE
Infect Dis Clin North Am; 2022 Jun; 36(2):397-421. PubMed ID: 35636907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
